Restaurant Fall Case Study: Elderly Patient, Hip Fracture, and Pharmacy Lien

James Wong — Founder & Pharmacist, LienScripts | February 12, 2026 | 9 min read

A 72-year-old woman slips on a wet outdoor patio at a restaurant, fracturing her hip and requiring open reduction and internal fixation surgery. Medicare covered some medications and denied others. A pharmacist from LienScripts flagged a dangerous drug interaction in the post-surgical anticoagulation regimen. The pharmacy lien filled every coverage gap across a complex 13-month polypharmacy case.

Case Background

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

The Client: Eleanora V., 72, a retired school librarian living independently in the San Diego area. She is described by her family as sharp, active, and independent — walking daily, attending a weekly book club, and managing her own household.

The Incident: On a warm Thursday evening, Eleanora and her daughter were dining at a popular outdoor restaurant in San Diego. After finishing dinner, Eleanora stepped onto the restaurant's outdoor patio — which was partially covered by a pergola — and slipped on a wet stone surface. The restaurant had recently hosed down the patio area, and the drainage slope was insufficient, leaving standing water pooled near the dining area. No wet floor warning was present.

Eleanora fell hard on her right side, striking the stone pavers directly. She was unable to stand on her own.

The Legal Basis:

Eleanora's daughter retained a personal injury attorney experienced in premises liability and elder fall cases. The claim was filed against the restaurant operator and, separately, the commercial property owner (the restaurant leased the space). The legal theory: both the operator and property owner had a duty to maintain safe premises for business invitees; the unmarked wet stone surface in a poorly-drained outdoor eating area was a foreseeable hazard; and the failure to dry, drain, or mark the area was a breach of that duty.

Medicare Coverage and Gaps:

Eleanora was enrolled in Medicare Part A and Part B with a Medicare supplement plan (Medigap). Medicare covered her emergency hospitalization, orthopedic surgery, and initial inpatient stay. However, a significant number of her medications — particularly post-surgical anticoagulation management, osteoporosis medications newly prescribed following fracture, and certain pain management agents — fell outside Medicare Part D formulary tier coverage or were subject to step therapy and prior authorization requirements.

Her PI attorney, familiar with pharmacy lien programs, enrolled Eleanora with LienScripts within the first month after discharge.


Injuries Sustained

Emergency imaging and surgical assessment confirmed:

  • Right femoral neck fracture — displaced, requiring urgent surgical repair
  • Right hip impaction injury — associated periarticular soft tissue bruising
  • Right wrist fracture (distal radius, non-displaced) — secondary impact from attempting to catch her fall
  • Lumbar contusion — resolved within 6 weeks

The femoral neck fracture was the critical injury. Displaced femoral neck fractures in elderly patients carry significant mortality risk if untreated and require prompt surgical stabilization. Eleanora was taken to the OR within 18 hours of presentation.


Surgical Intervention: Open Reduction and Internal Fixation (ORIF)

Eleanora's orthopedic surgeon performed an open reduction and internal fixation (ORIF) of the right femoral neck fracture. Hardware — multiple cannulated screws and a dynamic hip screw plate — was used to stabilize the fracture. The non-displaced distal radius fracture was managed with casting rather than surgery.

Post-operative considerations unique to elderly hip fracture patients:

  • Venous thromboembolism (VTE) prophylaxis — hip fracture surgery carries an elevated DVT/PE risk; anticoagulation is mandatory
  • Delirium prevention — narcotic exposure in elderly patients requires careful monitoring and minimization
  • Fall prevention and bone health — the fracture itself often reveals underlying osteoporosis that must be addressed to reduce future fracture risk
  • Polypharmacy risk — Eleanora had pre-existing prescriptions for hypertension, thyroid function, and arthritis management, creating significant drug interaction exposure

[!KEY] Hip fracture surgery in elderly patients involves mandatory post-operative anticoagulation, careful opioid minimization, and a new diagnosis of osteoporosis in many cases. This creates a complex polypharmacy environment where a pharmacist's active oversight is not optional — it is a patient safety requirement. LienScripts provides pharmacist oversight as a core component of its lien-based dispensing for exactly this reason.


Phase 1: Post-Surgical Anticoagulation and Pain Management (Months 1–3)

Eleanora's surgical team initiated warfarin for VTE prophylaxis following ORIF, targeting an INR of 2.0–3.0 for 30 days. INR monitoring was performed weekly through her primary care physician.

The interaction flag:

Within the first week of discharge, Eleanora's daughter called LienScripts to confirm her prescriptions. The reviewing pharmacist noted that Eleanora's pre-existing arthritis medication — a prescription-strength NSAID she had been taking for years — was still on her discharge medication list alongside warfarin. NSAIDs significantly potentiate warfarin's anticoagulant effect and dramatically increase the risk of gastrointestinal bleeding and intracranial hemorrhage in elderly patients on anticoagulation.

The LienScripts pharmacist contacted Eleanora's treating physician directly. The NSAID was discontinued immediately and replaced with a safer non-NSAID analgesic. The prescribing physician acknowledged the interaction had been overlooked in the discharge transition and thanked the pharmacist for catching it.

Medications enrolled on pharmacy lien (Phase 1):

Medication Indication Notes
Warfarin (INR-dosed) DVT/PE prophylaxis post-ORIF INR checks weekly; dose adjusted per result
Oxycodone/acetaminophen 5/325 mg Acute post-surgical pain Minimized due to elderly delirium risk; 2 weeks only
Methocarbamol 500 mg Periarticular muscle spasm Lower dose selected for elderly patient tolerability
Omeprazole 20 mg GI protection Continued through full anticoagulation period
Gabapentin 100 mg TID (titrated to 300 mg TID) Neuropathic pain at hip Low-and-slow titration for elderly; managed carefully

[!KEY] The pharmacy interaction flag in Eleanora's case — identifying a warfarin-NSAID interaction overlooked at hospital discharge — is a concrete example of how lien-based pharmacist oversight can prevent serious patient harm. Elderly patients transitioning from hospital to home with complex medication regimens are at peak risk for dangerous drug interactions. A pharmacist actively reviewing the full medication list, not just filling individual prescriptions, catches these errors before they reach the patient.

Transition to apixaban (Eliquis):

At the one-month mark, Eleanora's orthopedic surgeon transitioned her from warfarin to apixaban (Eliquis) 2.5 mg twice daily for extended VTE prophylaxis. The rationale: apixaban eliminates the need for frequent INR monitoring (which had required her daughter to drive her to the lab weekly), has a more predictable pharmacokinetic profile in elderly patients, and avoids the drug-food interactions that make warfarin management burdensome for patients living alone. The extended course was 6 months total given Eleanora's continued limited mobility.

Medicare Part D covered warfarin (generic tier) but placed apixaban on a higher tier requiring prior authorization. The prior authorization was denied on first submission. The pharmacy lien covered apixaban for the remainder of the anticoagulation period without interruption.


Phase 2: Osteoporosis Treatment and Rehabilitation (Months 3–8)

Bone density testing (DEXA scan) ordered by Eleanora's primary care physician confirmed significant osteoporosis — a T-score that placed her at high fracture risk. The hip fracture itself had been the sentinel event revealing undiagnosed osteoporosis. Her primary care physician initiated formal osteoporosis treatment.

New medications enrolled on pharmacy lien:

Medication Indication Notes
Alendronate 70 mg weekly Osteoporosis treatment (bisphosphonate) Per ortho and PCP co-management
Cholecalciferol (Vitamin D3) 2000 IU daily Vitamin D sufficiency for bone health Per PCP; OTC but documented and enrolled
Calcium carbonate 600 mg BID Calcium supplementation Co-prescribed with Vitamin D and alendronate
Apixaban 2.5 mg BID (continuing) Extended VTE prophylaxis Pharmacy lien continued through month 6

Medicare Part D covered alendronate (generic tier). However, the Vitamin D and calcium supplementation — while clinically standard in osteoporosis management — were denied as "over-the-counter" items despite prescription. The lien covered them.

Physical therapy in this phase focused on hip strengthening, balance and fall prevention training, and gait restoration. Eleanora also began occupational therapy to support her independence at home. By month five, she was ambulating with a cane. By month seven, she had transitioned to unassisted ambulation for shorter distances.


Phase 3: Chronic Pain Management and Final Documentation (Months 8–13)

By month eight, Eleanora's bone healing was confirmed on imaging and her anticoagulation course was complete. Remaining clinical issues:

  • Persistent right hip discomfort with activity (expected post-ORIF)
  • Right wrist stiffness and intermittent aching (residual from cast management of distal radius fracture)
  • Neuropathic pain at the right hip (from periarticular nerve involvement during ORIF)

Medications in final phase:

Medication Indication Duration
Gabapentin 300 mg TID (continued) Neuropathic hip pain Months 8–13
Topical diclofenac gel 1% Wrist and hip joint activity pain Months 8–13
Duloxetine 30 mg Added month 9 for neuropathic pain and mild depression related to functional loss Months 9–13
Alendronate 70 mg weekly (continuing) Ongoing osteoporosis management Beyond settlement

At month nine, Eleanora's primary care physician added duloxetine — an SNRI with dual indication for neuropathic pain and depression. Eleanora had expressed to her physician a significant sense of loss over her reduced independence and her fear of falling again. Duloxetine addressed both the clinical neuropathic component and the psychological dimension of her recovery.

Medicare denied duloxetine for the pain indication (required step therapy with two prior agents). The pharmacy lien covered it.


Settlement Documentation and the MERIT

LienScripts generated a comprehensive MERIT at month 13 covering the full treatment arc. The document organized medications across three clinical phases — acute post-surgical, rehabilitation and osteoporosis management, and chronic pain — with each phase's medications, dates, and prescribing physicians clearly mapped.

Key MERIT contributions to the premises liability demand:

  1. Anticoagulation complexity: The warfarin-to-apixaban transition, the duration of VTE prophylaxis, and the pharmacist-flagged interaction were all documented, establishing that Eleanora's recovery was not a simple fracture-and-heal case but a medically complex, high-risk recovery requiring sustained pharmaceutical management.

  2. New osteoporosis diagnosis: The introduction of bisphosphonate therapy at month three, triggered by fracture-revealing bone density loss, established a new ongoing medical condition caused by the fall. Osteoporosis treatment is a lifetime commitment — its initiation as a direct consequence of the fall contributed meaningfully to the future damages projection.

  3. Psychological impact: The duloxetine prescription, with its documented indication for neuropathic pain and adjustment to functional loss, provided a pharmacy anchor for the non-economic damages narrative about Eleanora's psychological harm from the fall.

  4. Pharmacist safety intervention: The documented interaction flag — which prevented a potentially life-threatening warfarin-NSAID combination — supported expert opinion testimony about the seriousness and complexity of elderly hip fracture management, and was cited in the demand letter as evidence of the ongoing medical risk Eleanora faced during recovery.


Settlement Outcome

The premises liability case settled with the restaurant operator and property owner's combined general liability carriers at month thirteen. The settlement reflected:

  • Significant orthopedic medical expenses (surgery, hospitalization, physician visits)
  • Physical therapy and occupational therapy
  • The pharmacy lien balance with LienScripts
  • Future medical expenses projection (ongoing osteoporosis management, possible hardware revision if hardware becomes symptomatic)
  • Non-economic damages: substantial, given Eleanora's age, her loss of independence during the recovery period, the psychological impact of the fall, and the permanent change in her fracture risk profile
  • Minor comparative fault assessment (disputed by plaintiff — ultimately allocated to defendant at a high percentage)

The LienScripts pharmacy lien was paid from settlement proceeds at closing.


Key Takeaways

  1. Elderly hip fracture cases involve polypharmacy complexity that demands pharmacist oversight. The volume and interaction risk of post-surgical medications — anticoagulants, pain agents, osteoporosis treatments, pre-existing chronic disease medications — make a pharmacist's active review essential to patient safety, not just billing management.

  2. The warfarin-NSAID interaction catch demonstrates real clinical value. LienScripts pharmacist oversight is not a passive dispensing function. In Eleanora's case, an actively engaged pharmacist identified a dangerous interaction overlooked at hospital discharge and prevented a potentially fatal complication.

  3. New diagnoses triggered by a fall expand the damages picture. When a fall reveals osteoporosis that will require lifetime management, that ongoing treatment exposure is a legitimate component of future damages in the premises liability demand.

  4. Medicare Part D gaps in elderly PI cases are predictable. Apixaban, duloxetine, and other medications frequently required for complex elderly patient recovery are subject to Medicare step therapy and prior authorization requirements. A pharmacy lien covers these gaps continuously while the PI case resolves.


Related Resources

Frequently Asked Questions

Does Medicare cover all medications after hip fracture surgery in a personal injury case?

Medicare Part D covers many medications but frequently requires step therapy, prior authorization, or higher cost-sharing for newer agents like apixaban (Eliquis) and certain SNRIs. In a personal injury case, a pharmacy lien covers medications that Medicare denies or places in high-cost tiers, allowing the patient to fill all prescribed medications at $0 out-of-pocket with the lien balance paid from settlement proceeds.

What is the warfarin-NSAID interaction, and why is it dangerous for elderly post-surgical patients?

Warfarin is a blood thinner used for DVT/PE prevention after hip fracture surgery. NSAIDs (like ibuprofen, naproxen, and prescription-strength arthritis medications) inhibit platelet function AND increase warfarin's anticoagulant effect, dramatically raising the risk of serious bleeding — including gastrointestinal hemorrhage and intracranial bleeding. In elderly patients, who often have multiple medications and fragile physiology, this interaction can be fatal. LienScripts pharmacist oversight is designed to identify exactly these kinds of dangerous interactions before they reach the patient.

Can a newly diagnosed condition caused by a fall be included in PI damages?

Yes. When a fall causes or reveals a condition requiring ongoing treatment — such as osteoporosis identified through bone density testing ordered after a fracture — the cost of that treatment is a legitimate component of future medical damages in the premises liability case. The defendant's negligence caused not only the immediate injury but the downstream medical management burden, including lifetime osteoporosis therapy.

How does a pharmacy lien work for elderly patients on Medicare?

For elderly patients on Medicare, a pharmacy lien covers the specific medications that Medicare denies, places in high cost-sharing tiers, or delays through step therapy or prior authorization. The patient fills all prescribed medications at $0 out-of-pocket through the lien program. At PI settlement, the pharmacy lien balance is paid from proceeds. Medicare's own subrogation interest — to the extent Medicare paid — is addressed separately in the settlement waterfall.